MSM & transgenders
The studies focus on groups where HIV infections are rising rapidly.
Warren said, “All of these activities in California are focused on men who have sex with men and transgender women. And that is entirely understandable and appropriate given the epidemic in the United States. That is the leading area of need. At the same time we really hope as advocates that these demonstration projects in California are the first of many and that many more will look at other populations.”
Those taking part in the study are being asked to follow what would appear to be a very simple drug regimen.
“It is a daily dose and it is a combined drug. It’s a single pill, but with both active tenofovir and emtricitabine. And it is the same dose that is provided to people who are infected with HIV, who use the same pill for treatment. So the recommendation that was studied in the trial was the same single pill every day,” he said
Daily dose
However, Warren said pre-exposure prophylaxis is only effective if people take the pill. So the studies will also examine why people may skip doses, even if they only have to swallow one pill a day.
“People who took this pill consistently had high levels, an excess of 70 percent reduction of risk. People who didn’t take the pill consistently didn’t get any benefit at all. There was no added protection,” he said.
最新
2013-11-25
2013-11-25
2013-11-25
2013-11-25
2013-11-25
2013-11-25